UBS Group’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
UBS Group's PLSE Position: Q3 2026 in Review
UBS Group reduced its Pulse Biosciences (PLSE) stake by 72% in Q3 2026, selling an estimated $8.34M and leaving 78,016 shares worth $3.89M. The position accounts for ﹤0.01% of the portfolio, ranked #4358.
UBS Group first reported a position in PLSE in Q2 2016 and has held it in 38 quarters since. The position peaked at $7.64M in Q2 2026. 142 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.
- UBS Group held 78,016 shares of Pulse Biosciences worth $3.89M as of Q3 2026.
- UBS Group sold 197,653 Pulse Biosciences shares in Q3 2026, an estimated $8.34M.
- Pulse Biosciences made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #4358 holding.
- UBS Group first reported a position in Pulse Biosciences in Q2 2016 and has held it in 38 quarters since.
- UBS Group's Pulse Biosciences position peaked at $7.64M in Q2 2026.
- 142 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.